🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 67080N119
- Previous Symbol
- PANA (changed 2/11/2021)
- Previous Name
- Panacea Acquisition Corp.
- Parent Company
- Nuvation Bio Inc. (NUVB)
Business: Nuvation Bio Inc. is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
Notes: Feb. 10, 2021 -- Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of its business combination with Panacea Acquisition Corp. (NYSE: PANA), a special purpose acquisition company (SPAC) sponsored by EcoR1 Capital. The resulting combined company will commence trading its shares on the New York Stock Exchange (NYSE) under the ticker symbol "NUVB" on February 11, 2021.
Company Contact
- CEO
- David Hung
- CFO
- Jennifer Fox
- Headquarters
- 1500 Broadway, Suite 1401, New York, NY 10036
- Phone
- 332-208-6102
- Investor Relations
- Kevin Murphy · 617-279-0589 · ir@nuvationbio.com